NLRX1 Knockout A-549 Cell Line
Cat.No.:
EDC07707
Species:
Human
Cell Name:
A-549
Gene:
NLRX1
Gene ID:
79671
Size:
1×10⁶cells
NLRX1 Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07707 |
|---|---|
| Product Name | NLRX1 Knockout A549 Cell Line |
| Cell Line | A-549 |
| Cellosaurus ID | CVCL_0023 |
| Cell Line Synonyms | A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 |
| Gene | NLRX1 |
| NCBI Gene ID | |
| Gene Synonyms | CLR11.3|DLNB26|NOD26|NOD5|NOD9 |
| Summary |
The protein encoded by this gene is a member of the NLR family and localizes to the outer mitochondrial membrane. The encoded protein is a regulator of mitochondrial antivirus responses. Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2013]
|
| Associated Diseases | Non-Small Cell Lung Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4 ,2days |
| Complete Culture Medium | F-12K + 10% FBS |
| Freezing Medium | 95% Complete culture medium + 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying NLRX1 function, NLRX1 Knockout A-549 Cell Line or NLRX1 overexpression A-549 Cell Line?
The choice depends on whether you are studying NLRX1's role as a mitochondrial NLR family member or its functions in MAVS-mediated antiviral signaling regulation and metabolic homeostasis. The Knockout line is the standard tool for asking whether NLRX1 is required for these processes — NLRX1 is uniquely localized to the mitochondrial outer membrane among NLR family members and negatively regulates MAVS-mediated type I interferon responses while contributing to mitochondrial metabolism. Overexpression is useful for studying NLRX1 in heterologous antiviral contexts.
For mitochondrial NLR and antiviral signaling research, the EDITGENE NLRX1 Knockout in A-549 is highly relevant — A-549 is widely used for respiratory virus research and NLRX1 regulates RIG-I-MAVS antiviral signaling against influenza and other RNA viruses. Rescue with wild-type or mitochondrial-targeting-deficient NLRX1 enables structure-function studies. The knockout is valuable for studying NLRX1's emerging role as a metabolic regulator and its dual functions in mitochondrial biology and innate immunity.
What are the application scenarios for this model?
Primary applications:
• Antiviral signaling: type I IFN response (IFN-β reporter, phospho-IRF3, phospho-TBK1) following viral infection or poly(I:C) stimulation in lung epithelial context.
• Respiratory virus replication: influenza, SARS-CoV-2, RSV replication assays in A-549 context — NLRX1 negatively regulates MAVS-mediated antiviral responses.
• Mitochondrial bioenergetics: Seahorse OCR/ECAR analysis given NLRX1's mitochondrial outer membrane localization and metabolic roles.
• Mitochondrial localization studies: confocal imaging of mitochondrial localization with TOM20/HSP60 co-staining in rescue cell lines.
EDITGENE recommends this model for researchers investigating mitochondrial NLR biology, RIG-I-MAVS antiviral signaling, and respiratory virus host factor research.
Is this NLRX1 Knockout A-549 Cell Line compatible with overexpression rescue experiments?
Yes. NLRX1 rescue experiments require attention to mitochondrial outer membrane targeting:
• Construct design: use a codon-modified NLRX1 sequence with a small C-terminal tag (FLAG, HA). NLRX1 has N-terminal mitochondrial targeting sequence directing to mitochondrial outer membrane, NACHT domain, and C-terminal LRR — N-terminal tags must not disrupt mitochondrial targeting.
• Mitochondrial localization validation: confirm mitochondrial outer membrane localization by TOM20 co-localization before functional assays.
• Mitochondrial-targeting-deficient rescue: N-terminal MTS truncation generates cytoplasmic NLRX1 for localization-function studies.
• Functional readout: rescue should restore MAVS antiviral signaling attenuation and mitochondrial bioenergetic profiles.
A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download